
Dysregulated cellular metabolism is a hallmark of cancer and many other diseases. Thus, many researchers are dedicated to detecting metabolites and the enzymes that catalyze their conversion in afflicted cells and associated immune components as biomarkers for disease progression and therapeutic efficacy. As new techniques are developed, and technology continues to advance, the interrogation of steady-state and dynamic metabolic activity has expanded from in vitro and ex vivo experiments to non-invasive, in vivo imaging. This Methods Collection will explore novel and established approaches to metabolic imaging that span basic, pre-clinical applications to translational and clinical implementation.
Evaluation of tumor acidosis in pre-clinical cancer models using in vivo PET/MRI
Alia Khaled1,
Mark D Pagel*1,
Chetan Dhakan1,
Xiaofei Liang1,
Lorenzo Palagi2,
Tyler R Pollard1,
Alyssa C Pollard3,
Elijah Gonzalez4,
William Schuler1,
Jorge de la Cerda1,
Federica Pisaneschi1,
Aikaterini Kotrotsou1
1Department of Cancer Systems Imaging, UT MD Anderson Cancer Center, Houston, TX, USA,
2Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy,
3Department of Chemistry, Stony Brook University, Stony Brook, NY, USA,
4Department of Chemistry, Rice University, Houston TX, USA
NADH-FLIM metabolic imaging of live in vitro tumors as a tool for novel anti-cancer treatment testing
Chiara Maria Mazzanti*1
1Fondazione Pisana per la Scienza
Evaluation of tumor acidosis in pre-clinical cancer models using in vivo acidoCEST MRI
Alia Khled1,
Mark D Pagel*2,
Tianzhe Li2,
William Schuler2,
Jorge de la Cerda2
1The University of Texas Health Science Center, Houston TX, USA,
2Department of Cancer Systems Imaging, UT MD Anderson Cancer Center